Trial Profile
Clinical Trials Insight: 700012980
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 May 2006
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors DURECT Corporation
- 01 May 2006 New trial record.